Login
Search
Search
0 Dates
2024
2023
2022
2021
2020
2019
2018
0 Events
CPC 2018
CPC 2019
Curso de Atualização em Medicina Cardiovascular 2019
Reunião Anual Conjunta dos Grupos de Estudo de Cirurgia Cardíaca, Doenças Valvulares e Ecocardiografia da SPC
CPC 2020
CPC 2021
CPC 2022
CPC 2023
CPC 2024
0 Topics
A. Basics
B. Imaging
C. Arrhythmias and Device Therapy
D. Heart Failure
E. Coronary Artery Disease, Acute Coronary Syndromes, Acute Cardiac Care
F. Valvular, Myocardial, Pericardial, Pulmonary, Congenital Heart Disease
G. Aortic Disease, Peripheral Vascular Disease, Stroke
H. Interventional Cardiology and Cardiovascular Surgery
I. Hypertension
J. Preventive Cardiology
K. Cardiovascular Disease In Special Populations
L. Cardiovascular Pharmacology
M. Cardiovascular Nursing
N. E-Cardiology / Digital Health, Public Health, Health Economics, Research Methodology
O. Basic Science
P. Other
0 Themes
01. History of Cardiology
02. Clinical Skills
03. Imaging
04. Arrhythmias, General
05. Atrial Fibrillation
06. Supraventricular Tachycardia (non-AF)
07. Syncope and Bradycardia
08. Ventricular Arrhythmias and Sudden Cardiac Death (SCD)
09. Device Therapy
10. Chronic Heart Failure
11. Acute Heart Failure
12. Coronary Artery Disease (Chronic)
13. Acute Coronary Syndromes
14. Acute Cardiac Care
15. Valvular Heart Disease
16. Infective Endocarditis
17. Myocardial Disease
18. Pericardial Disease
19. Tumors of the Heart
20. Congenital Heart Disease and Pediatric Cardiology
21. Pulmonary Circulation, Pulmonary Embolism, Right Heart Failure
22. Aortic Disease
23. Peripheral Vascular and Cerebrovascular Disease
24. Stroke
25. Interventional Cardiology
26. Cardiovascular Surgery
27. Hypertension
28. Risk Factors and Prevention
29. Rehabilitation and Sports Cardiology
30. Cardiovascular Disease in Special Populations
31. Pharmacology and Pharmacotherapy
32. Cardiovascular Nursing
33. e-Cardiology / Digital Health
34. Public Health and Health Economics
35. Research Methodology
36. Basic Science
37. Miscellanea
0 Resources
Abstract
Slides
Vídeo
Report
CLEAR FILTERS
Transcatheter aortic valve replacement: A durable alternative to surgical aortic valve approach?
Session:
Posters 2 - Écran 2 - Doença Valvular
Speaker:
Francisco Gama
Congress:
CPC 2019
Topic:
F. Valvular, Myocardial, Pericardial, Pulmonary, Congenital Heart Disease
Theme:
15. Valvular Heart Disease
Subtheme:
15.4 Valvular Heart Disease – Treatment
Session Type:
Posters
FP Number:
---
Authors:
Francisco Fernandes Gama; Rui Campante Teles; Maria João Andrade; João Brito; Pedro de Araújo Gonçalves; Gustavo Mendes; José Maria Farinha; Luis Oliveira; Eduarda Horta; Carla Reis; Manuel Almeida; Jorge Santos Ferreira; Miguel Mendes
Abstract
<p><strong>Background: </strong>Several trials are currently evaluating transcatheter aortic valve replacement for treating patients with low surgical risk and longer life expectancies. The potential rapid progression of structural valve degeneration (SVD) in patients with renal failure can be used as a surrogate to compare transcatheter (TAVR) versus surgical (SAVR) bioprostheses durability.</p> <p><strong>Methods: </strong>Single-centre retrospective cohort study of consecutive severely depressed renal function patients (glomerular filtration rate ≤30 mL/min) that underwent surgical or trancatheter aortic valve replacement between September 2007 and October 2017, including 103 patients (37 TAVR Vs 66 SAVR). At least one-year follow up was needed for study inclusion. SVD was accessed through echocardiographic criteria defined by Eltchaninoff et al. as a mean transvalvular gradient >20 mm Hg in combination with an increase of at least 10 mm Hg from the 30-day echocardiography and/or regurgitation grade ≥3 that was not initially present. Kaplen-meier analysis was performed to access superiority between strategies.</p> <p><strong>Results: </strong>Total follow up was available in 92% of overall patients (32 TAVR/ 62 SAVR). TAVR patients tended to have higher prevalence of diabetes, dyslipidemia, peripheral artery disease, previous myocardial infarction and previous cardiac surgery. Twelve pats revealed echocardiographic criteria of SVD, 3 within TAVR group (9,1%). SVD incidence by Kaplan-Meier analysis did not differ (<em>p=0,12</em> Log-rank Test; see figure).</p> <p><strong>Conclusion: </strong>In renal failure patients, TAVR was as durable as SAVR.</p>
Slides
Our mission: To reduce the burden of cardiovascular disease
Visit our site
